The American Journal of Surgery
Volume 198, Issue 4 , Pages 495-499 , October 2009

The predictive value of incidental PET/CT findings suspicious for breast cancer in women with non-breast malignancies

  • John S. Beatty, M.D.

      Affiliations

    • Department of Surgery, Medical College of Georgia, Augusta, GA, USA
    • ,
  • Hadyn T. Williams, M.D.

      Affiliations

    • Department of Radiology, Medical College of Georgia, Augusta, GA, USA
    • ,
  • Angela L. Gucwa, M.D.

      Affiliations

    • Department of Surgery, Medical College of Georgia, Augusta, GA, USA
    • ,
  • Matthew P. Hughes, B.S.

      Affiliations

    • School of Medicine, Medical College of Georgia, Augusta, GA, USA
    • ,
  • Viren S. Vasudeva, B.A.

      Affiliations

    • School of Medicine, Medical College of Georgia, Augusta, GA, USA
    • ,
  • Beau A. Aldridge, B.S.

      Affiliations

    • School of Medicine, Medical College of Georgia, Augusta, GA, USA
    • ,
  • Deborah M. Fields, C.N.M.T., M.Ed.

      Affiliations

    • Department of Radiology, Medical College of Georgia, Augusta, GA, USA
    • ,
  • George S. David, M.S.

      Affiliations

    • Department of Radiology, Medical College of Georgia, Augusta, GA, USA
    • ,
  • D. Scott Lind, M.D.

      Affiliations

    • Department of Surgery, Medical College of Georgia, Augusta, GA, USA
    • ,
  • E. James Kruse, D.O.

      Affiliations

    • Department of Surgery, Medical College of Georgia, Augusta, GA, USA
    • ,
  • James M. McLoughlin, M.D.

      Affiliations

    • Department of Surgery, Medical College of Georgia, Augusta, GA, USA
    • Corresponding Author InformationCorresponding author. Tel.: 706-721-4728; fax: 706-721-9136

Received 24 March 2009 ,Revised 14 June 2009

References 

  1. David G, Gibbs D, Williams H. A comprehensive PET/CT database for tracking patient variables. Radiol Manage. 2008;30:35–39
  2. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27–41
  3. Knutson D, Steiner E. Screening for breast cancer: current recommendations and future directions. Am Fam Physician. 2007;75:1660–1666
  4. Humphrey LL, Helfand M, Chan BK, et al. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:347–360
  5. McBean AM, Yu X, Virnig BA. Screening mammography rate and predictors following treatment for colorectal cancer. J Cancer Surviv. 2009;3:12–20
  6. Snyder CF, Frick KD, Kantsiper ME, et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009;27:1054–1061
  7. Oeffinger KC, Ford JS, Moskowitz CS, et al. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA. 2009;301:404–414
  8. Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21:4386–4394
  9. Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2004;141:590–597
  10. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22:4979–4990
  11. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. http://www.survivorshipguidelines.orgAccessed March 20, 2009
  12. Yang SK, Cho N, Moon WK. The role of PET/CT for evaluating breast cancer. Korean J Radiol. 2007;8:429–437
  13. Radan L, Ben-Haim S, Bar-Shalom R, et al. The role of FDG-PET/CT in suspected recurrence of breast cancer. Cancer. 2006;107:2545–2551
  14. Isasi CR, Moadel RM, Blaufox MD. A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat. 2005;90:105–112
  15. Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480–508
  16. Gil-Rendo A, Martinez-Regueira F, Zornoza G, et al. Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer. Br J Surg. 2009;96:166–170
  17. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med. 2005;46:752–757
  18. Agress H, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology. 2004;230:417–422
  19. Choi JY, Lee KS, Kwon OJ, et al. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol. 2005;23:7654–7659
  20. Wang G, Lau EW, Shakher R. How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT?. Cancer. 2007;109:117–124
  21. Lee ST, Tan T, Poon AM, et al. Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-D-glucose-avid colon lesions. Mol Imaging Biol. 2008;10:48–53
  22. Kamel EM, Thumshirn M, Truninger K, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med. 2004;45:1804–1810
  23. Israel O, Yefremov N, Bar-Shalom R, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46:758–762
  24. Basu S, Houseni M, Alavi A. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management. Nucl Med Commun. 2008;29:367–373
  25. Choi JY, Lee KS, Kim HJ, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med. 2006;47:609–615
  26. Eloy JA, Brett EM, Fatterpekar GM, et al. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer. AJNR Am J Neuroradiol. 2009;30:1431–1434
  27. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun. 2009;30:240–244

PII: S0002-9610(09)00347-X

doi: 10.1016/j.amjsurg.2009.06.009

The American Journal of Surgery
Volume 198, Issue 4 , Pages 495-499 , October 2009

Article Tools

* Image Usage & Resolution